Autres langues Spectral Medical Inc.

Actions

EDT

CA8475771033

Marché Fermé - Toronto S.E. Autres places de cotation 21:59:47 19/04/2024			Varia. 5j.	Varia. 1 janv.
0,44 ^CAD	0,00 %		0,00 %	+3,53 %

10/04	Spectral Medical fait le point sur l'essai Tigris	CI
02/04	Spectral Medical Inc. annonce des changements au sein de son conseil d'administration	CI

Autres langues

Débloquez toutes les actualités sur toutes les entreprises : Ne manquez plus une opportunité d'investissement rentable !

Inscription 100% Gratuite

Spectral Medical Updated on Tigris Trial	10/04
Spectral Medical Brief: Providing Tigris Trial Update; 101 patients enrolled	10/04
Spectral Medical Provides Tigris Trial Update	10/04
Spectral Medical Provides Tigris Trial Update	10/04
North American Morning Briefing : Investors on -2-	05/04
Spectral Medical Brief: Paul Walker will immediately succeed Bihl as Chair	02/04
Spectral Medical Brief: Anthony Bihl III, Spectral's Chairman, will be retiring from the Board at Upcoming Shareholder Meeting in June 2024	02/04
Spectral Medical Chair to Retire From the Board of Directors	02/04
Spectral Medical Inc. Announces Board Changes	02/04
Spectral Medical Brief: Says Total of 97 patients randomized to date out of the 150 total patients to be enrolled in the Tigris trial	28/03
Spectral Medical Brief: Q4 Revenue $365,000; Loss was $6,479,000, or $0.02 per share	28/03
Spectral Medical Announces Fourth Quarter and Fiscal 2023 Results and Provides Corporate Update	28/03
Spectral Medical Inc. Reports Earnings Results for the Full Year Ended December 31, 2023	28/03
North American Morning Briefing : Stocks Struggle After New Records	22/03
Spectral Medical Provides February Tigris Trial Update	28/02
Spectral Medical Inc. Provides Update on the Company's Tigris Trial	28/02
Spectral Medical Brief: Providing February Tigris Trial Update; 93 patients enrolled; February represents a second record breaking consecutive month for patient enrollment	28/02
Spectral Medical Provides February Tigris Trial Update	28/02
Spectral Medical Says PMX Distribution and Supply Agreement with Baxter International Extended for 10 Years	21/02
Spectral Medical Brief: Baxter to act as Exclusive partner to Spectral for 10 years following PMX approval by U.S. FDA	21/02

Aucun résultat pour cette recherche

Toute l'actualité Reco analystes Faits marquants Insiders Transcripts Communiqués Publications officielles Autres langues Idées de trading Articles Zonebourse Analyses Zonebourse

Autres langues Spectral Medical Inc.

Actions

EDT

CA8475771033

Autres langues

Filtres